Dr. Beckwith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3188 Bellevue Ave
Cincinnati, OH 45219Phone+1 513-475-8500Fax+1 513-584-8554
Education & Training
Ohio State University College of MedicineClass of 2014
Certifications & Licensure
OH State Medical License 2018 - 2025- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 7 citationsPatient characteristics that predict Richter's transformation in patients with chronic lymphocytic leukemia treated with ibrutinib.Adam S Kittai, Ying Huang, Kyle A Beckwith, Seema A Bhat, David A Bond
American Journal of Hematology. 2023-01-01 - 21 citationsLeukemic B Cell CTLA-4 Suppresses Costimulation of T Cells.Priscilla Do, Kyle A. Beckwith, Carolyn Cheney, Minh Tran, Larry Beaver
Journal of Immunology. 2019-05-01 - 263 citationsIbrutinib treatment improves T cell number and function in CLL patientsMeixiao Long, Kyle A. Beckwith, Priscilla Do, Bethany L. Mundy, Amber Gordon
The Journal of Clinical Investigation. 2017-07-17
Press Mentions
Three Founding Trustees Retire from PVCH Foundation BoardMay 27th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
